The average speed of the model (step length/step duration), <i>v</i>, vs. the phase of a perturbation pulse, <i>φ</i> for a pulse of constant amplitude and duration. by Jooeun Ahn (299192)

“…<p>When a pulse is located in a swing phase, it cannot accelerate the model, and <i>v</i> is lower than when the entire pulse is inside double stance. …”

Fig 4 - by Kirralise J. Hansford (20670869)

Time course of 95% Area, X and Y Amplitude Sway during postural training. by Cristina Dolciotti (16317330)

TAD analysis for <i>Sox10.</i> by Hongjoo An (21703199)

Analysis of correlations between identified metabolites and steroid hormones with general characteristic data. by Saoraya Chanmuang (13242534)

X-band EPR spectra and ANS fluorescence analysis of SsTroA. by Beiwen Zheng (221103)

“…(B) Fluorescence changes in the intensity emission for SsTroA indicate a metal dependent decrease in hydrophobic residue exposure. …”

Model-predicted effect of once a day administration of 1000 mg of acetazolamide. by Nicholas Heming (510208)

“…Minute ventilation is predicted to increase by more than 0.75 l min⁻¹ in 65% of patients (A) and PaCO₂ is predicted to decrease by 5 mmHg in 45% of patients (B) supported by pressure support ventilation treated by 1000 mg day⁻¹ of acetazolamide. …”

Evolution of R ratio (total consumer biomass change divided by NPP change) in regards to SST increase relative to reference period. by Vianney Guibourd de Luzinais (16871842)

“…<p>Where NPP is expected to decrease (a), or increase (b) under IPSL-SSP5-8.5 combination. …”

S9 Fig - by Vianney Guibourd de Luzinais (16871842)

Consolidation of training-induced changes in unipedal stance: 95% Area, Y Sway Amplitude and LFS. by Cristina Dolciotti (16317330)

Consolidation of training-induced changes in unipedal stance: Path Length, X Sway Amplitude and Velocity. by Cristina Dolciotti (16317330)

Ensemble projections of NPP and total consumer biomass changes, relative to 1995–2014, under SSP5-8.5 and for all the considered MEMs. by Vianney Guibourd de Luzinais (16871842)

Combined illusion score index across conditions (NI: Non-Illusion; NIT: Non-Illusion Tactile; MS: Multisensory; UV: Unimodal Visual). by Kirralise J. Hansford (20670869)

Controls for the UAS RNAi lines show similar average activity and sleep in 10 day old males. by Jessie E. Landis (16378731)

Conformational Study of 9-Dehydro-9-Trifluoromethyl Cinchona Alkaloids via ¹⁹F NMR Spectroscopy: Emergence of Trifluoromethyl Moiety as a Conformational Stabilizer and a... by G. K. Surya Prakash (1419985)

“…The trifluoromethyl substituent has been incorporated into quinidine as a conformational stabilizer and a probe to provide straightforward insight into the conformational behavior of cinchona alkaloids. …”

Conformational Study of 9-Dehydro-9-Trifluoromethyl Cinchona Alkaloids via ¹⁹F NMR Spectroscopy: Emergence of Trifluoromethyl Moiety as a Conformational Stabilizer and a... by G. K. Surya Prakash (1419985)

“…The trifluoromethyl substituent has been incorporated into quinidine as a conformational stabilizer and a probe to provide straightforward insight into the conformational behavior of cinchona alkaloids. …”

Table 1_Global, regional, and national burden of falls from 1990 to 2021: a comprehensive analysis with a focus on falls attributable to reduced bone mass and projections to 2045.d... by Yi Liu (36759)

“…Analysis of falls attributable to reduced bone mass found that women's DALYs were higher than men's after the age of 50, and there was a general decreasing trend in DALYs for the 40–59 age group, followed by an increase after 2019. …”

Predictions of vaccination model for adults aged 60-74y. by Matthias Horn (78815)

Results of the fitting process of the basic epidemiological model (i.e., without vaccinations). by Matthias Horn (78815)

Supplementary Material for: Effects of a DPP4 Inhibitor on Progression of NASH-related HCC and the p62/ Keap1/Nrf2-Pentose Phosphate Pathway in a Mouse Model by Kawaguchi T. (5713799)

“…<b><i>Background and Aims:</i></b> Diabetes mellitus is a risk factor for hepatocellular carcinoma (HCC) in patients with nonalcoholic steatohepatitis (NASH). …”